S&P 500   3,313.72 (-0.24%)
DOW   29,059.52 (-0.43%)
QQQ   223.98 (+0.05%)
AAPL   317.93 (+0.07%)
FB   220.11 (-0.55%)
MSFT   166.15 (+0.27%)
GOOGL   1,486.12 (+0.13%)
AMZN   1,881.07 (-0.34%)
CGC   24.37 (+1.04%)
NVDA   251.69 (+0.66%)
BABA   218.05 (-1.94%)
MU   59.52 (+0.59%)
GE   11.73 (+3.17%)
TSLA   566.21 (-0.59%)
AMD   51.29 (-0.27%)
T   38.63 (-1.05%)
ACB   2.04 (+0.00%)
F   9.04 (-1.31%)
NFLX   343.88 (+5.48%)
BAC   33.92 (-1.28%)
GILD   63.06 (-0.58%)
S&P 500   3,313.72 (-0.24%)
DOW   29,059.52 (-0.43%)
QQQ   223.98 (+0.05%)
AAPL   317.93 (+0.07%)
FB   220.11 (-0.55%)
MSFT   166.15 (+0.27%)
GOOGL   1,486.12 (+0.13%)
AMZN   1,881.07 (-0.34%)
CGC   24.37 (+1.04%)
NVDA   251.69 (+0.66%)
BABA   218.05 (-1.94%)
MU   59.52 (+0.59%)
GE   11.73 (+3.17%)
TSLA   566.21 (-0.59%)
AMD   51.29 (-0.27%)
T   38.63 (-1.05%)
ACB   2.04 (+0.00%)
F   9.04 (-1.31%)
NFLX   343.88 (+5.48%)
BAC   33.92 (-1.28%)
GILD   63.06 (-0.58%)
S&P 500   3,313.72 (-0.24%)
DOW   29,059.52 (-0.43%)
QQQ   223.98 (+0.05%)
AAPL   317.93 (+0.07%)
FB   220.11 (-0.55%)
MSFT   166.15 (+0.27%)
GOOGL   1,486.12 (+0.13%)
AMZN   1,881.07 (-0.34%)
CGC   24.37 (+1.04%)
NVDA   251.69 (+0.66%)
BABA   218.05 (-1.94%)
MU   59.52 (+0.59%)
GE   11.73 (+3.17%)
TSLA   566.21 (-0.59%)
AMD   51.29 (-0.27%)
T   38.63 (-1.05%)
ACB   2.04 (+0.00%)
F   9.04 (-1.31%)
NFLX   343.88 (+5.48%)
BAC   33.92 (-1.28%)
GILD   63.06 (-0.58%)
S&P 500   3,313.72 (-0.24%)
DOW   29,059.52 (-0.43%)
QQQ   223.98 (+0.05%)
AAPL   317.93 (+0.07%)
FB   220.11 (-0.55%)
MSFT   166.15 (+0.27%)
GOOGL   1,486.12 (+0.13%)
AMZN   1,881.07 (-0.34%)
CGC   24.37 (+1.04%)
NVDA   251.69 (+0.66%)
BABA   218.05 (-1.94%)
MU   59.52 (+0.59%)
GE   11.73 (+3.17%)
TSLA   566.21 (-0.59%)
AMD   51.29 (-0.27%)
T   38.63 (-1.05%)
ACB   2.04 (+0.00%)
F   9.04 (-1.31%)
NFLX   343.88 (+5.48%)
BAC   33.92 (-1.28%)
GILD   63.06 (-0.58%)
Log in
(Ad)
Did you know that you could generate up to $1,529.70 in passive income per month without risking your retirement? A virtually unheard-of investment plan is finally letting everyday Americans invest in cannabis without betting the house. The best part? This plan has been around for over 50 years!

NYSEARCA:PPH - VanEck Vectors Pharmaceutical ETF Stock Price, Forecast & News

$66.32
-0.46 (-0.69 %)
(As of 01/23/2020 12:33 PM ET)
Add
Today's Range
$66.13
Now: $66.32
$66.49
50-Day Range
$62.20
MA: $64.32
$66.81
52-Week Range
$54.48
Now: $66.32
$67.00
Volume4,464 shs
Average Volume70,307 shs
Market Capitalization$184.90 million
P/E RatioN/A
Dividend Yield1.70%
BetaN/A

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Pharmaceutical ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:PPH
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionGlobal

Fund Statistics

Assets Under Management$185.94 million
Average Daily Volume$47,947.50
Discount/Premium0.04%

ETF Expenses

Management Fee0.35%
Other Expenses0.05%
Total Expenses0.40%
Fee Waiver-0.05%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerIMC Chicago

Receive PPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Currency Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Sector Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Industry Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)

(Ad)

A U.S. congressional committee passed important legislation that enables each state to set its own policies around cannabis… This bill also allows states to expunge federal marijuana convictions and arrests. This will likely lead to federal legalization sooner than expected. Get in early and you just might be the next 'Marijuana Millionaire'...

VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH) Frequently Asked Questions

What is VanEck Vectors Pharmaceutical ETF's stock symbol?

VanEck Vectors Pharmaceutical ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PPH."

How often does VanEck Vectors Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Vectors Pharmaceutical ETF?

VanEck Vectors Pharmaceutical ETF announced a quarterly dividend on Monday, December 30th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.1729 per share on Monday, January 6th. This represents a $0.69 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date of this dividend is Monday, December 30th. View VanEck Vectors Pharmaceutical ETF's Dividend History.

Has VanEck Vectors Pharmaceutical ETF been receiving favorable news coverage?

News coverage about PPH stock has been trending very negative this week, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. VanEck Vectors Pharmaceutical ETF earned a news sentiment score of -3.6 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for VanEck Vectors Pharmaceutical ETF.

What other stocks do shareholders of VanEck Vectors Pharmaceutical ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Pharmaceutical ETF investors own include Intel (INTC), Icon (ICLR), Gilead Sciences (GILD), FOX (FOX), Fonar (FONR), Cisco Systems (CSCO), Cirrus Logic (CRUS), Costco Wholesale (COST), Comcast (CMCSA) and Amgen (AMGN).

Who are VanEck Vectors Pharmaceutical ETF's major shareholders?

VanEck Vectors Pharmaceutical ETF's stock is owned by a number of of institutional and retail investors. Top institutional investors include IFP Advisors Inc (0.02%).

Which major investors are buying VanEck Vectors Pharmaceutical ETF stock?

PPH stock was acquired by a variety of institutional investors in the last quarter, including IFP Advisors Inc.

How do I buy shares of VanEck Vectors Pharmaceutical ETF?

Shares of PPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is VanEck Vectors Pharmaceutical ETF's stock price today?

One share of PPH stock can currently be purchased for approximately $66.32.

How big of a company is VanEck Vectors Pharmaceutical ETF?

VanEck Vectors Pharmaceutical ETF has a market capitalization of $184.90 million. View Additional Information About VanEck Vectors Pharmaceutical ETF.

What is VanEck Vectors Pharmaceutical ETF's official website?

The official website for VanEck Vectors Pharmaceutical ETF is http://www.vaneck.com/.


MarketBeat Community Rating for VanEck Vectors Pharmaceutical ETF (NYSEARCA PPH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  72
MarketBeat's community ratings are surveys of what our community members think about VanEck Vectors Pharmaceutical ETF and other stocks. Vote "Outperform" if you believe PPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: Cryptocurrencies

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel